Sio Capital Management as of March 31, 2020
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 69 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amgen (AMGN) | 7.2 | $22M | 106k | 202.73 | |
McKesson Corporation (MCK) | 6.0 | $18M | 132k | 135.26 | |
Coherus Biosciences (CHRS) | 5.9 | $18M | 1.1M | 16.22 | |
Cel Sci (CVM) | 5.0 | $15M | 1.3M | 11.54 | |
Gw Pharmaceuticals Plc ads | 4.9 | $15M | 168k | 87.57 | |
Biogen Idec (BIIB) | 4.4 | $13M | 42k | 316.37 | |
Anthem (ELV) | 4.4 | $13M | 58k | 227.05 | |
Boston Scientific Corporation (BSX) | 4.3 | $13M | 396k | 32.63 | |
Envista Hldgs Corp (NVST) | 4.3 | $13M | 857k | 14.94 | |
Allergan | 3.3 | $9.7M | 55k | 177.11 | |
SPDR Gold Trust (GLD) | 3.2 | $9.6M | 65k | 148.05 | |
United Therapeutics Corporation (UTHR) | 2.9 | $8.6M | 91k | 94.82 | |
Rts/bristol-myers Squibb Compa | 2.9 | $8.5M | 2.2M | 3.80 | |
Vanda Pharmaceuticals (VNDA) | 2.5 | $7.5M | 721k | 10.36 | |
Merck & Co (MRK) | 2.4 | $7.2M | 93k | 76.94 | |
Hca Holdings (HCA) | 2.3 | $7.0M | 78k | 89.85 | |
I Mab (IMAB) | 2.1 | $6.1M | 473k | 13.00 | |
UnitedHealth (UNH) | 1.8 | $5.5M | 22k | 249.36 | |
Teva Pharmaceutical Industries (TEVA) | 1.7 | $5.1M | 573k | 8.98 | |
Radius Health | 1.7 | $5.0M | 387k | 13.00 | |
Molina Healthcare (MOH) | 1.7 | $5.0M | 36k | 139.72 | |
Zimmer Holdings (ZBH) | 1.6 | $4.8M | 47k | 101.09 | |
Quanterix Ord (QTRX) | 1.5 | $4.4M | 237k | 18.37 | |
Mei Pharma | 1.3 | $4.0M | 2.5M | 1.61 | |
Arena Pharmaceuticals | 1.2 | $3.6M | 85k | 41.99 | |
Ardelyx (ARDX) | 1.2 | $3.5M | 622k | 5.68 | |
Viking Therapeutics (VKTX) | 1.2 | $3.5M | 752k | 4.68 | |
Walgreen Boots Alliance (WBA) | 1.1 | $3.2M | 69k | 45.75 | |
Syneos Health | 1.0 | $3.0M | 77k | 39.43 | |
Syros Pharmaceuticals | 0.9 | $2.8M | 469k | 5.93 | |
Esperion Therapeutics (ESPR) | 0.9 | $2.5M | 81k | 31.53 | |
Alkermes (ALKS) | 0.8 | $2.5M | 170k | 14.42 | |
Lifesci Acquisition Corp unit 03/31/2025 | 0.7 | $2.1M | 210k | 10.00 | |
Mednax (MD) | 0.7 | $2.1M | 177k | 11.64 | |
Osmotica Pharmaceuticals (RVLPQ) | 0.6 | $1.8M | 575k | 3.18 | |
Zafgen | 0.6 | $1.8M | 2.3M | 0.77 | |
Immunovant (IMVT) | 0.6 | $1.8M | 114k | 15.56 | |
Leap Therapeutics | 0.6 | $1.7M | 1.1M | 1.58 | |
Trillium Therapeutics, Inc. Cmn | 0.6 | $1.7M | 418k | 4.04 | |
Affimed Therapeutics B V | 0.5 | $1.6M | 1.0M | 1.58 | |
Ascendis Pharma A S (ASND) | 0.5 | $1.6M | 14k | 112.61 | |
Healthequity (HQY) | 0.5 | $1.6M | 31k | 50.59 | |
Medpace Hldgs (MEDP) | 0.5 | $1.5M | 21k | 73.40 | |
Kadmon Hldgs | 0.5 | $1.4M | 338k | 4.19 | |
AmerisourceBergen (COR) | 0.5 | $1.4M | 16k | 88.52 | |
Aslan Pharmaceuticals Adr ads | 0.4 | $1.3M | 1.3M | 1.02 | |
Verastem | 0.4 | $1.3M | 492k | 2.64 | |
Harrow Health (HROW) | 0.4 | $1.2M | 312k | 3.82 | |
Neoleukin Therapeutics | 0.3 | $1.0M | 88k | 11.39 | |
Mersana Therapeutics (MRSN) | 0.3 | $969k | 166k | 5.83 | |
Catalyst Biosciences | 0.3 | $956k | 219k | 4.37 | |
Nextgen Healthcare | 0.3 | $946k | 91k | 10.43 | |
Dyadic International (DYAI) | 0.3 | $935k | 180k | 5.20 | |
Progyny (PGNY) | 0.3 | $913k | 43k | 21.18 | |
Atreca Inc Cl A (BCEL) | 0.3 | $782k | 47k | 16.55 | |
Morphic Hldg (MORF) | 0.2 | $729k | 50k | 14.67 | |
Kodiak Sciences (KOD) | 0.2 | $716k | 15k | 47.73 | |
Immunovant Inc *w exp 12/18/202 | 0.2 | $715k | 308k | 2.32 | |
Supernus Pharmaceuticals (SUPN) | 0.2 | $450k | 25k | 18.00 | |
Aravive | 0.1 | $441k | 77k | 5.76 | |
Provention Bio | 0.1 | $387k | 42k | 9.19 | |
Rapt Therapeutics (RAPT) | 0.1 | $304k | 14k | 21.26 | |
Amarin Corporation (AMRN) | 0.1 | $200k | 50k | 4.00 | |
Cymabay Therapeutics | 0.1 | $196k | 133k | 1.48 | |
Sierra Oncology | 0.1 | $151k | 15k | 9.81 | |
Mirum Pharmaceuticals (MIRM) | 0.1 | $150k | 11k | 14.02 | |
Menlo Therapeutics | 0.0 | $61k | 23k | 2.66 | |
Bellicum Pharmaceuticals | 0.0 | $58k | 12k | 4.73 | |
Mesoblast Ltd- | 0.0 | $35k | 8.1k | 4.32 |